StockVS

Cartesian Growth Corporation III (CGCT) Análisis de acciones

Servicios Financieros

Cartesian Growth Corporation III

$10.85

+$0.99 (+10.04%)

Última actualización: 26 de mayo de 2026

Historial de Precios

Análisis

Descripción de la empresa

Cartesian Growth Corporation III is a shell company incorporated in New York, New York in 2024, with its primary business focus on effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities. The company operates within the Financial Services sector and specifically within the industry of Shell Companies, a classification that indicates the entity currently lacks an operational business model and exists primarily to facilitate future corporate transactions. In terms of scale, the company holds a total market capitalization of $354.32M, while its annual revenue is not available for reporting, and the employee count is listed as N/A. The substantial market cap figure relative to the absence of reported revenue and employee data suggests that the company's valuation is driven entirely by market speculation regarding potential future business combinations rather than current operational earnings or established workforce metrics.

Salud financiera

The company reports a net income of $6.22M over the trailing twelve months, yet the revenue figure is not available, making it impossible to directly calculate the efficiency of revenue generation from current operations. The gap between the available net income and the unavailable revenue highlights a unique structural characteristic where earnings are likely derived from transaction costs, fees, or specific financial engineering activities common in shell companies, rather than traditional sales margins. Free cash flow stands at $-244,656, indicating that the company is currently burning cash, which reflects the high liquidity requirements often necessary to maintain a shell structure or fund transaction-related expenses before a merger is consummated. All three margin metrics—gross margin, operating margin, and profit margin—are reported at 0.0%, which signifies that the company is not generating profit from the sale of goods or services in a traditional sense, as it has no operational revenue stream to support these margins. The company holds cash reserves of $624,163, while debt data is unavailable, preventing a direct calculation of the debt-to-equity ratio, though the presence of cash without listed debt suggests a conservative stance regarding external borrowing at this specific moment. The current ratio is 0.89, a figure below 1.0 that indicates the company's current assets are insufficient to cover its current liabilities without liquidating non-current assets or obtaining additional financing. Return on equity is not available, but the return on assets is recorded at -0.5%, revealing that for every dollar of assets employed, the company is generating a slight negative return, a typical profile for a pre-merger entity waiting for a transaction to occur.

Evaluación de valoración

The trailing twelve-month P/E ratio is 41.08, while the forward P/E ratio is not available, a discrepancy that implies the market is pricing the stock based on historical profitability without having a clear view of future earnings expectations due to the lack of forecastable revenue. The price-to-book ratio is -26.81, a negative figure that indicates the market values the company at a level significantly below its book value, reflecting the high risk associated with investing in a shell company that may dissolve or fail to complete a merger. The price-to-sales ratio and EV/EBITDA are both not available, suggesting that traditional valuation multiples are not applicable or meaningful given the absence of sales data and the inability to calculate enterprise value multiples without consistent EBITDA figures. The 52-week high is $10.42 and the 52-week low is $10.00, meaning the stock is trading within a very narrow band less than 5% of the high, which suggests low volatility and limited price movement relative to the broader market range. The beta value is not available, so a direct comparison of price volatility relative to the broader market cannot be calculated, but the tight trading range between the high and low implies that the stock price is largely decoupled from general market fluctuations driven by sector-wide sentiment.

Growth & Income

The revenue growth year-over-year and earnings growth year-over-year are both not available, which prevents a direct comparison of earnings growth rates against revenue growth rates, as the company has no historical revenue data to establish a growth trajectory. Since the company does not pay dividends, the dividend yield is not available and the payout ratio is 0.0%, indicating that the company retains all available earnings, if any, rather than distributing them to shareholders. This reinvestment strategy is typical for shell companies, as any retained capital is intended to be deployed toward the costs of finding and executing a business combination rather than providing immediate income to investors. The overall growth and income profile is characterized by a complete absence of historical growth metrics and dividend income, relying entirely on the potential value creation from a future merger to provide any return to shareholders.

Comparación con pares

Cartesian Growth Corporation III (CGCT) opera en la industria de Empresas Fantasma. Así se compara con sus pares más cercanos por capitalización de mercado:

Empresa Ticker Cap. de Mercado Ratio P/E
Cartesian Growth Corporation III CGCT $449.19M 36.2
Twenty One Capital, Inc. XXI $2.49B N/A
Churchill Capital Corp X CCCX $711.00M N/A
Drugs Made In America Acquisition II Corp. DMII $641.46M 77.5

El ratio P/E promedio de la industria Empresas Fantasma es 82.8x. Cartesian Growth Corporation III cotiza a un P/E de 36.2.

Este análisis es generado por IA solo con fines informativos y no constituye asesoramiento financiero. Los datos pueden estar retrasados o ser inexactos. Siempre realice su propia investigación y consulte a un asesor financiero calificado antes de tomar decisiones de inversión.

Acerca de Cartesian Growth Corporation III

Cartesian Growth Corporation III does not have significant operations. It focuses on effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities. Cartesian Growth Corporation III was incorporated in 2024 and is based in New York, New York.

La descripción de la empresa se muestra en inglés.

Visitar sitio web →

Estadísticas Clave

Capitalización
$449.19M
Ratio P/E
36.17
Máximo 52 Sem.
$10.93
Mínimo 52 Sem.
$9.26
Volumen Promedio
218.23K

Datos proporcionados por Yahoo Finance a través de yfinance. Actualizado diariamente.

Información de la Empresa

Bolsa
NASDAQ
País
United States